Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.

Identifieur interne : 000318 ( PubMed/Curation ); précédent : 000317; suivant : 000319

Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.

Auteurs : Takashi Suzuki [Japon] ; Tadanobu Takahashi ; Chao-Tan Guo ; Kazuya I-P Jwa Hidari ; Daisei Miyamoto ; Hideo Goto ; Yoshihiro Kawaoka ; Yasuo Suzuki

Source :

RBID : pubmed:16140748

Descripteurs français

English descriptors

Abstract

N2 neuraminidase (NA) genes of the 1957 and 1968 pandemic influenza virus strains possessed avian-like low-pH stability of sialidase activity, unlike most epidemic strains. We generated four reverse-genetics viruses from a genetic background of A/WSN/33 (H1N1) that included parental N2 NAs of 1968 pandemic (H3N2) and epidemic (H2N2) strains or their counterpart N2 NAs in which the low-pH stability of the sialidase activity was changed by substitutions of one or two amino acid residues. We found that the transfectant viruses bearing low-pH-stable sialidase (WSN/Stable-NAs) showed 25- to 80-times-greater ability to replicate in Madin-Darby canine kidney (MDCK) cells than did the transfectant viruses bearing low-pH-unstable sialidase (WSN/Unstable-NAs). Enzymatic activities of WSN/Stable-NAs were detected in endosomes of MDCK cells after 90 min of virus internalization by in situ fluorescent detection with 5-bromo-4-chloro-indole-3-yl-alpha-N-acetylneuraminic acid and Fast Red Violet LB. Inhibition of sialidase activity of WSN/Stable-NAs on the endocytic pathway by pretreatment with 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid (zanamivir) resulted in a significant decrease in progeny viruses. In contrast, the enzymatic activities of WSN/Unstable-NAs, the replication of which had no effect on pretreatment with zanamivir, were undetectable in cells under the same conditions. Hemadsorption assays of transfectant-virus-infected cells revealed that the low-pH stability of the sialidase had no effect on the process of removal of sialic acid from hemagglutinin in the Golgi regions. Moreover, high titers of viruses were recovered from the lungs of mice infected with WSN/Stable-NAs on day 3 after intranasal inoculation, but WSN/Unstable-NAs were cleared from the lungs of the mice. These results indicate that sialidase activity in late endosome/lysosome traffic enhances influenza A virus replication.

DOI: 10.1128/JVI.79.18.11705-11715.2005
PubMed: 16140748

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:16140748

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.</title>
<author>
<name sortKey="Suzuki, Takashi" sort="Suzuki, Takashi" uniqKey="Suzuki T" first="Takashi" last="Suzuki">Takashi Suzuki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences and COE Program in the 21st Century, Shizuoka 422-8526, Japan. Suzukit@u-shizuoka-ken.ac.jp</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences and COE Program in the 21st Century, Shizuoka 422-8526</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Takahashi, Tadanobu" sort="Takahashi, Tadanobu" uniqKey="Takahashi T" first="Tadanobu" last="Takahashi">Tadanobu Takahashi</name>
</author>
<author>
<name sortKey="Guo, Chao Tan" sort="Guo, Chao Tan" uniqKey="Guo C" first="Chao-Tan" last="Guo">Chao-Tan Guo</name>
</author>
<author>
<name sortKey="Hidari, Kazuya I P Jwa" sort="Hidari, Kazuya I P Jwa" uniqKey="Hidari K" first="Kazuya I-P Jwa" last="Hidari">Kazuya I-P Jwa Hidari</name>
</author>
<author>
<name sortKey="Miyamoto, Daisei" sort="Miyamoto, Daisei" uniqKey="Miyamoto D" first="Daisei" last="Miyamoto">Daisei Miyamoto</name>
</author>
<author>
<name sortKey="Goto, Hideo" sort="Goto, Hideo" uniqKey="Goto H" first="Hideo" last="Goto">Hideo Goto</name>
</author>
<author>
<name sortKey="Kawaoka, Yoshihiro" sort="Kawaoka, Yoshihiro" uniqKey="Kawaoka Y" first="Yoshihiro" last="Kawaoka">Yoshihiro Kawaoka</name>
</author>
<author>
<name sortKey="Suzuki, Yasuo" sort="Suzuki, Yasuo" uniqKey="Suzuki Y" first="Yasuo" last="Suzuki">Yasuo Suzuki</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16140748</idno>
<idno type="pmid">16140748</idno>
<idno type="doi">10.1128/JVI.79.18.11705-11715.2005</idno>
<idno type="wicri:Area/PubMed/Corpus">000318</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000318</idno>
<idno type="wicri:Area/PubMed/Curation">000318</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000318</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.</title>
<author>
<name sortKey="Suzuki, Takashi" sort="Suzuki, Takashi" uniqKey="Suzuki T" first="Takashi" last="Suzuki">Takashi Suzuki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences and COE Program in the 21st Century, Shizuoka 422-8526, Japan. Suzukit@u-shizuoka-ken.ac.jp</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences and COE Program in the 21st Century, Shizuoka 422-8526</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Takahashi, Tadanobu" sort="Takahashi, Tadanobu" uniqKey="Takahashi T" first="Tadanobu" last="Takahashi">Tadanobu Takahashi</name>
</author>
<author>
<name sortKey="Guo, Chao Tan" sort="Guo, Chao Tan" uniqKey="Guo C" first="Chao-Tan" last="Guo">Chao-Tan Guo</name>
</author>
<author>
<name sortKey="Hidari, Kazuya I P Jwa" sort="Hidari, Kazuya I P Jwa" uniqKey="Hidari K" first="Kazuya I-P Jwa" last="Hidari">Kazuya I-P Jwa Hidari</name>
</author>
<author>
<name sortKey="Miyamoto, Daisei" sort="Miyamoto, Daisei" uniqKey="Miyamoto D" first="Daisei" last="Miyamoto">Daisei Miyamoto</name>
</author>
<author>
<name sortKey="Goto, Hideo" sort="Goto, Hideo" uniqKey="Goto H" first="Hideo" last="Goto">Hideo Goto</name>
</author>
<author>
<name sortKey="Kawaoka, Yoshihiro" sort="Kawaoka, Yoshihiro" uniqKey="Kawaoka Y" first="Yoshihiro" last="Kawaoka">Yoshihiro Kawaoka</name>
</author>
<author>
<name sortKey="Suzuki, Yasuo" sort="Suzuki, Yasuo" uniqKey="Suzuki Y" first="Yasuo" last="Suzuki">Yasuo Suzuki</name>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Cell Line</term>
<term>Dogs</term>
<term>Endocytosis</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Enzyme Stability</term>
<term>Guanidines</term>
<term>Humans</term>
<term>Hydrogen-Ion Concentration</term>
<term>Influenza A virus (drug effects)</term>
<term>Influenza A virus (enzymology)</term>
<term>Influenza A virus (genetics)</term>
<term>Influenza A virus (physiology)</term>
<term>Influenza, Human (virology)</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Neuraminidase (antagonists & inhibitors)</term>
<term>Neuraminidase (genetics)</term>
<term>Neuraminidase (metabolism)</term>
<term>Pyrans</term>
<term>Sialic Acids (pharmacology)</term>
<term>Transfection</term>
<term>Virus Replication (drug effects)</term>
<term>Virus Replication (genetics)</term>
<term>Virus Replication (physiology)</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acides sialiques (pharmacologie)</term>
<term>Animaux</term>
<term>Antienzymes (pharmacologie)</term>
<term>Chiens</term>
<term>Concentration en ions d'hydrogène</term>
<term>Endocytose</term>
<term>Grippe humaine (virologie)</term>
<term>Guanidines</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Mâle</term>
<term>Pyrannes</term>
<term>Réplication virale ()</term>
<term>Réplication virale (génétique)</term>
<term>Réplication virale (physiologie)</term>
<term>Sialidase (antagonistes et inhibiteurs)</term>
<term>Sialidase (génétique)</term>
<term>Sialidase (métabolisme)</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Stabilité enzymatique</term>
<term>Transfection</term>
<term>Virus de la grippe A ()</term>
<term>Virus de la grippe A (enzymologie)</term>
<term>Virus de la grippe A (génétique)</term>
<term>Virus de la grippe A (physiologie)</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Enzyme Inhibitors</term>
<term>Sialic Acids</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Sialidase</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Influenza A virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Influenza A virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Réplication virale</term>
<term>Sialidase</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Sialidase</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Acides sialiques</term>
<term>Antienzymes</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Réplication virale</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Influenza A virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Line</term>
<term>Dogs</term>
<term>Endocytosis</term>
<term>Enzyme Stability</term>
<term>Guanidines</term>
<term>Humans</term>
<term>Hydrogen-Ion Concentration</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Pyrans</term>
<term>Transfection</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Chiens</term>
<term>Concentration en ions d'hydrogène</term>
<term>Endocytose</term>
<term>Guanidines</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Mâle</term>
<term>Pyrannes</term>
<term>Réplication virale</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Stabilité enzymatique</term>
<term>Transfection</term>
<term>Virus de la grippe A</term>
<term>Zanamivir</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">N2 neuraminidase (NA) genes of the 1957 and 1968 pandemic influenza virus strains possessed avian-like low-pH stability of sialidase activity, unlike most epidemic strains. We generated four reverse-genetics viruses from a genetic background of A/WSN/33 (H1N1) that included parental N2 NAs of 1968 pandemic (H3N2) and epidemic (H2N2) strains or their counterpart N2 NAs in which the low-pH stability of the sialidase activity was changed by substitutions of one or two amino acid residues. We found that the transfectant viruses bearing low-pH-stable sialidase (WSN/Stable-NAs) showed 25- to 80-times-greater ability to replicate in Madin-Darby canine kidney (MDCK) cells than did the transfectant viruses bearing low-pH-unstable sialidase (WSN/Unstable-NAs). Enzymatic activities of WSN/Stable-NAs were detected in endosomes of MDCK cells after 90 min of virus internalization by in situ fluorescent detection with 5-bromo-4-chloro-indole-3-yl-alpha-N-acetylneuraminic acid and Fast Red Violet LB. Inhibition of sialidase activity of WSN/Stable-NAs on the endocytic pathway by pretreatment with 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid (zanamivir) resulted in a significant decrease in progeny viruses. In contrast, the enzymatic activities of WSN/Unstable-NAs, the replication of which had no effect on pretreatment with zanamivir, were undetectable in cells under the same conditions. Hemadsorption assays of transfectant-virus-infected cells revealed that the low-pH stability of the sialidase had no effect on the process of removal of sialic acid from hemagglutinin in the Golgi regions. Moreover, high titers of viruses were recovered from the lungs of mice infected with WSN/Stable-NAs on day 3 after intranasal inoculation, but WSN/Unstable-NAs were cleared from the lungs of the mice. These results indicate that sialidase activity in late endosome/lysosome traffic enhances influenza A virus replication.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">16140748</PMID>
<DateCompleted>
<Year>2005</Year>
<Month>10</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-538X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>79</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2005</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.</ArticleTitle>
<Pagination>
<MedlinePgn>11705-15</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>N2 neuraminidase (NA) genes of the 1957 and 1968 pandemic influenza virus strains possessed avian-like low-pH stability of sialidase activity, unlike most epidemic strains. We generated four reverse-genetics viruses from a genetic background of A/WSN/33 (H1N1) that included parental N2 NAs of 1968 pandemic (H3N2) and epidemic (H2N2) strains or their counterpart N2 NAs in which the low-pH stability of the sialidase activity was changed by substitutions of one or two amino acid residues. We found that the transfectant viruses bearing low-pH-stable sialidase (WSN/Stable-NAs) showed 25- to 80-times-greater ability to replicate in Madin-Darby canine kidney (MDCK) cells than did the transfectant viruses bearing low-pH-unstable sialidase (WSN/Unstable-NAs). Enzymatic activities of WSN/Stable-NAs were detected in endosomes of MDCK cells after 90 min of virus internalization by in situ fluorescent detection with 5-bromo-4-chloro-indole-3-yl-alpha-N-acetylneuraminic acid and Fast Red Violet LB. Inhibition of sialidase activity of WSN/Stable-NAs on the endocytic pathway by pretreatment with 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid (zanamivir) resulted in a significant decrease in progeny viruses. In contrast, the enzymatic activities of WSN/Unstable-NAs, the replication of which had no effect on pretreatment with zanamivir, were undetectable in cells under the same conditions. Hemadsorption assays of transfectant-virus-infected cells revealed that the low-pH stability of the sialidase had no effect on the process of removal of sialic acid from hemagglutinin in the Golgi regions. Moreover, high titers of viruses were recovered from the lungs of mice infected with WSN/Stable-NAs on day 3 after intranasal inoculation, but WSN/Unstable-NAs were cleared from the lungs of the mice. These results indicate that sialidase activity in late endosome/lysosome traffic enhances influenza A virus replication.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Takashi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences and COE Program in the 21st Century, Shizuoka 422-8526, Japan. Suzukit@u-shizuoka-ken.ac.jp</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takahashi</LastName>
<ForeName>Tadanobu</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Guo</LastName>
<ForeName>Chao-Tan</ForeName>
<Initials>CT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hidari</LastName>
<ForeName>Kazuya I-P Jwa</ForeName>
<Initials>KI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Miyamoto</LastName>
<ForeName>Daisei</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Goto</LastName>
<ForeName>Hideo</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kawaoka</LastName>
<ForeName>Yoshihiro</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Yasuo</ForeName>
<Initials>Y</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006146">Guanidines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011714">Pyrans</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012794">Sialic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.1.18</RegistryNumber>
<NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>L6O3XI777I</RegistryNumber>
<NameOfSubstance UI="D053243">Zanamivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004705" MajorTopicYN="N">Endocytosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004795" MajorTopicYN="N">Enzyme Stability</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006146" MajorTopicYN="N">Guanidines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011714" MajorTopicYN="N">Pyrans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012794" MajorTopicYN="N">Sialic Acids</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053243" MajorTopicYN="N">Zanamivir</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2005</Year>
<Month>9</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2005</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2005</Year>
<Month>9</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">16140748</ArticleId>
<ArticleId IdType="pii">79/18/11705</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.79.18.11705-11715.2005</ArticleId>
<ArticleId IdType="pmc">PMC1212606</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2002 Oct;76(20):10455-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12239322</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2002 Jul;83(Pt 7):1729-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12075092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 2003 May 22;543(1-3):71-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12753908</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2003 Jun 2;22(11):2717-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12773387</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 2004 Jan 16;557(1-3):228-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14741372</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Nov;78(22):12665-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15507653</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1974 Oct;61(2):397-410</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4472498</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1977 Oct;24(1):170-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">561860</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1980 Dec;107(2):313-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7456332</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1983 Jul 15;128(1):260-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6880029</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Biochem. 1986;55:663-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2874766</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Biochem. 1987;56:365-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3304138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gene. 1991 Dec 15;108(2):193-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1660837</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Rev Biochem Mol Biol. 1992;27(1-2):57-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1727693</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1993 Jun 3;363(6428):418-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8502295</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1993 Nov;67(11):6667-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8411368</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protein Sci. 1995 Jun;4(6):1081-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7549872</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 1996 May;133(4):733-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8666660</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Glycoconj J. 1997 Apr;14(3):379-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9147061</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1997 Nov;78 ( Pt 11):2821-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9367368</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1998 Mar 13;273(11):6518-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9497387</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10224-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9707628</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1998 Nov;72(11):8550-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9765393</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem J. 1998 Dec 1;336 ( Pt 2):271-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9820800</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1999 Jan;80 ( Pt 1):137-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9934696</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10430945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Jan;74(1):547-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10590147</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Jul;74(14):6316-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10864641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biochem. 2001 Aug;130(2):279-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11481046</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2001 Sep 7;293(5536):1840-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11546875</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Glycoconj J. 2001 Apr;18(4):331-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11788801</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 May;76(9):4603-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11932425</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Histochem Cell Biol. 2002 May;117(5):453-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12029493</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10718-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12149448</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000318 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000318 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:16140748
   |texte=   Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:16140748" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021